The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.

MLA

Trad, Karim S., et al. “The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-Effective.” Surgical Innovation, vol. 25, no. 2, Apr. 2018, pp. 149–57. EBSCOhost, https://doi.org/10.1177/1553350618755214.

APA

Trad, K. S., Barnes, W. E., Prevou, E. R., Simoni, G., Steffen, J. A., Shughoury, A. B., Raza, M., Heise, J. A., Fox, M. A., & Mavrelis, P. G. (2018). The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective. Surgical Innovation, 25(2), 149–157. https://doi.org/10.1177/1553350618755214

Chicago

Trad, Karim S, William E Barnes, Elizabeth R Prevou, Gilbert Simoni, Jennifer A Steffen, Ahmad B Shughoury, Mamoon Raza, Jeffrey A Heise, Mark A Fox, and Peter G Mavrelis. 2018. “The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-Effective.” Surgical Innovation 25 (2): 149–57. doi:10.1177/1553350618755214.